Make an Appointment
-
Austin J Ma, MD A Professional Corporation1700 E Cesar E Chavez Avenue, 3500, Los Angeles, CA 90033 map
-
Austin J Ma, MD a Professional Corporation1851 Lombard Street, Suite 105, Oxnard, CA 93030 map
-
Austin J Ma, MD a Professional Corporation412 W Carroll Avenue, Suite 210, Glendora, CA 91741 map
-
Austin J Ma, MD a Professional Corporation1700 Cesar E Chavez Avenue, Suite 3500, Los Angeles, CA 90033 map
Dr. Shilpa Shah is a hematologist / oncologist in Los Angeles. She is a cancer specialist trained in blood disorders and the medical treatment of malignancies.
Austin J Ma, MD A Professional Corporation
Accepting New Patients?
Yes, Dr. Shilpa R. Shah is accepting new patients at this office.
Phone
Fax
(323) 226-2899
Address
1700 E Cesar E Chavez Avenue, 3500, Los Angeles, CA 90033
Office Details
Austin J Ma, MD a Professional Corporation
Austin J Ma, MD a Professional Corporation
Austin J Ma, MD a Professional Corporation
Insurance Accepted
- Medicare
Bio
Dr. Shilpa Shah graduated from Indiana University School of Medicine in 2007.
Dr. Shah has four offices in California where she specializes in Hematology / Oncology.
Dr. Shah works with five doctors including Dr. Rahul Naik and Dr. David Masiello.
Specialty
-
Hematology / Oncology
As a hematologist / oncologist in California, Dr. Shah is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Shah may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Shah may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Education & Training
Languages Spoken
- English
Latest Hematology / Oncology News
-
Catnip: The 'Why' Behind Cats' Favorite HighRobert Preidt, Dec 10, 2018 at 12:00 PM
-
Incontinence Drug May Cut Hot Flashes in Breast Cancer SurvivorsSteven Reinberg, HealthDay Reporter, Dec 7, 2018 at 9:00 AM
-
Healthy Lifestyle Lowers Odds of Breast Cancer's ReturnRobert Preidt, Dec 7, 2018 at 9:00 AM